Bergerot C - Search Results

1

Use of telehealth for psychosocial oncology: A mixed methods study about barriers to and opportunities with Latino patients from Latin America, Spain, and the United States.

Ruda-Santolaria L, Bergerot C, Hernandez J, Pena C, Montana MF, Galindo-Vazquez O, Torres-Blasco N, Castro-Figueroa E, Esenarro L, Sanchez-Ramirez JC, Estapé T, Gany F, Costas-Muniz R. Ruda-Santolaria L, et al. Among authors: bergerot c. Psychooncology. 2023 Aug;32(8):1289-1297. doi: 10.1002/pon.6182. Epub 2023 Jun 27. Psychooncology. 2023. PMID: 37370195

2

COVID-19 and financial toxicity in patients with renal cell carcinoma.

Staehler MD, Battle DJ, Bergerot CD, Pal SK, Penson DF. Staehler MD, et al. World J Urol. 2021 Jul;39(7):2559-2565. doi: 10.1007/s00345-020-03476-6. Epub 2020 Oct 22. World J Urol. 2021. PMID: 33090258 Free PMC article.

3

The Role of Circulating Tumor DNA in Renal Cell Carcinoma.

Bergerot PG, Hahn AW, Bergerot CD, Jones J, Pal SK. Bergerot PG, et al. Curr Treat Options Oncol. 2018 Feb 20;19(2):10. doi: 10.1007/s11864-018-0530-4. Curr Treat Options Oncol. 2018. PMID: 29464405 Review.

4

Counterbalancing COVID-19 with Cancer Surveillance and Therapy: A Survey of Patients with Renal Cell Carcinoma.

Staehler M, Battle D, Pal SK, Bergerot CD. Staehler M, et al. Eur Urol Focus. 2021 Nov;7(6):1355-1362. doi: 10.1016/j.euf.2020.09.002. Epub 2020 Sep 11. Eur Urol Focus. 2021. PMID: 32943372 Free PMC article.

5

Biopsychosocial distress and clinical outcome in metastatic renal cell carcinoma.

Bergerot CD, Clark KL, Ashing KT, Bergerot PG, Obenchain R, Dizman N, Hsu J, Philip E, Loscalzo M, Pal SK. Bergerot CD, et al. Palliat Support Care. 2019 Jun;17(3):353-355. doi: 10.1017/S1478951518000342. Epub 2018 Jun 18. Palliat Support Care. 2019. PMID: 29911518

6

Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status.

Bergerot CD, Philip EJ, Bergerot PG, Hsu J, Dizman N, Salgia M, Salgia N, Vaishampayan U, Battle D, Loscalzo M, Dale W, Pal SK. Bergerot CD, et al. Cancer. 2021 Feb 1;127(3):354-358. doi: 10.1002/cncr.33238. Epub 2020 Oct 2. Cancer. 2021. PMID: 33007114 Free article.

7

Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma.

Pal SK, Bergerot P, Dizman N, Bergerot C, Adashek J, Madison R, Chung JH, Ali SM, Jones JO, Salgia R. Pal SK, et al. Among authors: bergerot p, bergerot c. Eur Urol. 2018 Jul;74(1):124-128. doi: 10.1016/j.eururo.2018.03.032. Eur Urol. 2018. PMID: 29685646 No abstract available.

8

Patient-reported Outcome Measures in Metastatic Urinary Cancers.

Bergerot CD, Bergerot PG, Philip EJ, Pal SK. Bergerot CD, et al. Eur Urol Focus. 2020 Jan 15;6(1):26-30. doi: 10.1016/j.euf.2019.02.020. Epub 2019 Mar 8. Eur Urol Focus. 2020. PMID: 30858072 Review.

9

Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma.

Bergerot CD, Battle D, Philip EJ, Bergerot PG, Msaouel P, Smith A', Bamgboje AE, Shuch B, Derweesh IH, Jonasch E, Stern AP, Pal SK, Staehler M. Bergerot CD, et al. JCO Oncol Pract. 2020 Nov;16(11):e1264-e1271. doi: 10.1200/OP.20.00105. Epub 2020 Sep 18. JCO Oncol Pract. 2020. PMID: 32955409

10

Quality of life, anxiety and depression in head and neck cancer patients: a randomized clinical trial.

Hortense FTP, Bergerot CD, Domenico EBL. Hortense FTP, et al. Rev Esc Enferm USP. 2020 Mar 27;54:e03546. doi: 10.1590/S1980-220X2018040103546. eCollection 2020. Rev Esc Enferm USP. 2020. PMID: 32236346 Free article. Clinical Trial. English, Portuguese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page